本页面由Tiger Trade Technology Pte. Ltd.提供服务

Castle Biosciences, Inc.

32.95
+0.19000.58%
成交量:12.01万
成交额:395.01万
市值:10.07亿
市盈率:-50.37
高:33.35
开:32.79
低:32.23
收:32.76
52周最高:44.28
52周最低:17.72
股本:3,054.95万
流通股本:2,821.96万
量比:0.37
换手率:0.43%
股息:- -
股息率:- -
每股收益(TTM):-0.6542
每股收益(LYR):-0.8334
净资产收益率:-4.20%
总资产收益率:-1.36%
市净率:2.14
市盈率(LYR):-39.54

数据加载中...

2024/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/02

重要事件披露

Form 8-K - Current report
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/13

SEC问询函

Form CORRESP - Correspondence
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report